Rinvoq (Upadacitinib) 15 mg tablets are used to treat moderate to severe rheumatoid arthritis, ulcerative colitis, and other inflammatory conditions by inhibiting Janus kinase (JAK) enzymes./Description: Rinvoq contains Upadacitinib, a selective Janus kinase (JAK) inhibitor, that works by targeting specific enzymes involved in the inflammatory process. It is prescribed for moderate to severe rheumatoid arthritis in adults who have not responded well to other treatments. Additionally, it is used to manage other autoimmune conditions, such as ulcerative colitis. Rinvoq helps reduce inflammation, pain, and joint damage while improving the patient's overall function and quality of life.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
